Korsana Biosciences, Inc. (KRSA) on GreekSoup

Korsana Biosciences, Inc.: Form 144, MICHAEL HIGGINS plans to sell 1,107 shares worth $35,424 around 22 October 2026

Thu, 22 Oct 2026 00:00:00 +0000

Form 144. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. filed DEF 14A: def 14a

Thu, 15 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13G/A filed by J. Wood Capital Advisors LLC, 0.1% of the class

Thu, 15 Oct 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: short interest 23,804 shares at the 15 October 2026 settlement, 1.00 days to cover

Thu, 15 Oct 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13G/A filed by FMR LLC, 6.9% of the class

Wed, 07 Oct 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. filed PRE 14A: pre 14a

Mon, 05 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: short interest 11,552 shares at the 30 September 2026 settlement, 1.00 days to cover

Wed, 30 Sep 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Form 144, ERROL B DE SOUZA plans to sell 4,903 shares worth $171,556 around 23 September 2026

Wed, 23 Sep 2026 00:00:00 +0000

Form 144. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Form 144, ERROL B DE SOUZA plans to sell 100 shares worth $3,499 around 22 September 2026

Tue, 22 Sep 2026 00:00:00 +0000

Form 144. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Form 144, ERROL B DE SOUZA plans to sell 2,139 shares worth $74,844 around 18 September 2026

Fri, 18 Sep 2026 00:00:00 +0000

Form 144. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13G filed by GENERAL ATLANTIC, L.P., 6.8% of the class

Fri, 18 Sep 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13G filed by Wellington Biomedical Innovation Master Investors (Cayman) II, L.P., 6.1% of the class

Wed, 16 Sep 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13D filed by Venrock Healthcare Capital Partners III, L.P., 9.9% of the class

Tue, 15 Sep 2026 00:00:00 +0000

The Reporting Persons purchased the aforementioned securities for investment purposes with the aim of increasing the value of their investments and the Issuer. Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to time in open market or private transactions, depending on its evaluation of the Issuer's business, prospects and financial condition, the market for the Issuer's securities, other developments concerning the Issuer, the reaction of the Issuer to the Reporting Persons' ownership of the Issuer's sec

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: short interest 4,442 shares at the 15 September 2026 settlement, 1.00 days to cover

Tue, 15 Sep 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. filed 8-K: material agreement, acquisition or disposition completed, results of operations, unregistered sale of equity, change to security holders' rights, change in control, officer or director change, charter or bylaw amendment, or fiscal year change, code of ethics amendment, shell company status, regulation fd disclosure

Fri, 11 Sep 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13D filed by Fairmount Funds Management LLC, 20.0% of the class

Fri, 11 Sep 2026 00:00:00 +0000

The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of September 8, 2026. The Reporting Persons' securities include (a) 2,691 shares of Common Stock issuable upon the exercise of options held directly by Mr. Kiselak that are currently exercisable or will be exercisable within 60 days of the date of this filing, (b) 6,911,174 shares of Common Stock directly held by Fund II and (c) 2,192,555 shares of Common Stock directly held by Co-Invest, and exclude (i) 2,074,000 shares of Common Stock issuable upon conversion of 2,074 sh

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. filed 8-K: shareholder vote, other events

Thu, 27 Aug 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. filed 8-K: other events

Tue, 25 Aug 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13G filed by BALYASNY ASSET MANAGEMENT L.P., 7.3% of the class

Fri, 14 Aug 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc.: Schedule 13G filed by ADAR1 Capital Management, LLC, 7.0% of the class

Fri, 14 Aug 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. Q2 FY2026 results: revenue $0, net income -$2 million

Tue, 04 Aug 2026 00:00:00 +0000

Results. The filing. The page on GreekSoup.

Korsana Biosciences, Inc. filed 10-Q: 10-q

Tue, 04 Aug 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.